QuickView for CDC20A;jsessionid=B67DA98E7EBB8BA755F41AE782C6E071;jsessionid=64C148EC82606D1FD9CBE48150DEB2DB;jsessionid=AF45F1C5ED602D850DF573E4D0BC9881;jsessionid=7C1D3F07AF7554C3B9B48E34F14F40F7;jsessionid=54F3673C7200879125CBE2BAD67EC9FF;jsessionid=22316CF17EE97C4A665BCF7C43E057F4 (gene)

1. Targeting Cdc20 for cancer therapy.
2. Current Progress and Perspectives of CDC20 in Female Reproductive Cancers.
3. Alternative CDC20 translational isoforms tune mitotic arrest duration.
4. CDC20 is a potential target gene to inhibit the tumorigenesis of MDCK cells.
5. Conditional knockout of Cdc20 attenuates osteogenesis in craniofacial bones.

There were no clinical trials for CDC20A;jsessionid=B67DA98E7EBB8BA755F41AE782C6E071;jsessionid=64C148EC82606D1FD9CBE48150DEB2DB;jsessionid=AF45F1C5ED602D850DF573E4D0BC9881;jsessionid=7C1D3F07AF7554C3B9B48E34F14F40F7;jsessionid=54F3673C7200879125CBE2BAD67EC9FF;jsessionid=22316CF17EE97C4A665BCF7C43E057F4